Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Four executives to...

    Four executives to leave Reckitt Benckiser amid company struggles

    Written by Ruby Khatun Khatun Published On 2017-09-06T10:47:31+05:30  |  Updated On 6 Sept 2017 10:47 AM IST
    Four executives to leave Reckitt Benckiser amid company struggles

    LONDON: Four senior executives are leaving Reckitt Benckiser Group as the British consumer goods company fights to recover from the weakest performance in its history.


    The maker of Durex condoms and Lysol cleaners on Monday confirmed the upcoming departures of the heads of human resources, information technology, developing markets and category development.


    The voluntary departures also come as Reckitt integrates Mead Johnson, its biggest takeover ever.


    The company has also been grappling for months with the fallout from a failed product launch and a safety scandal in South Korea that wiped out its business there.


    Darrell Stein, senior vice president of information services, will leave on October 1, to be immediately replaced by Seth Cohen, who will join the company from PepsiCo.


    Stein’s departure comes months after Reckitt was hit by a cyber attack that hobbled its global operations and cost it about 100 million pounds of sales this year.


    Deborah Yates, senior vice president of human resources, and Roberto Funari, executive vice president of category development, will leave at the end of the year to pursue other opportunities, Reckitt said.


    Frederic Larmuseau, head of developing markets, will also leave at the end of the year, Reckitt said, to take the helm of Jacobs Douwe Egberts, a coffee business owned by JAB Holdings. His departure was announced six weeks ago.


    “RB is transforming itself to become the undisputed leader in global consumer health and hygiene and has taken a number of important steps on this strategic journey over the last six months. This journey is driving a change in our portfolio priorities and, over time, how we operate,” the company said in a statement.


    “We remain confident that we have the right strategy and the considerable bench strength of talent to deliver significant and sustainable value creation for all of our stakeholders.”


    Reckitt's shares were down 1.1 percent at 0815 GMT, underperforming a FTSE 100. FTSE that was down 0.2 percent.


    The departures were first reported by the Financial Times.




    (Reporting by Martinne Geller; editing by Jason Neely)



    companyDarrell SteinDeborah YatesDurexDurex condomsFour executiveshuman resourcesinformation technologyleaveLysol cleanersReckitt BenckiserSeth Cohenstruggles
    Source : REUTERS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok